Jonathan E. Gold

Federated Investment Management Co. (FIMCO) is a mutual fund manager and SEC-registered investment advisor headquartered in Pittsburgh, Pennsylvania. The firm is a subsidiary of FII Holdings, Inc., owned by Federated Hermes, Inc. (NYSE: FHI). FIMCO offers domestic and international equity, fixed-income and money market mutual funds, and a variety of separate account options for many investors.

Amphion Capital Management LLC (Amphion Capital) is a venture capital firm subsidiary of Amphion Innovations Plc founded in 1995 by Richard Morgan and Robert Bertoldi. The firm is headquartered in New York.

Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY.

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.

Amphion Capital Partners LLC used to create, develop and operate healthcare and technology companies in partnership with corporations, universities and others seeking to profitably commercialize intellectual property. Focusing on long-term growth and profitability, the company's management team had collectively created and developed more than 50 technology-driven companies in the information technology, physical and life sciences industries. In the physical and life sciences industries, these companies include Celgene, Medisense, Quidel, and SEQUUS. The company was headquartered in New York, NY.